|
Market Closed -
NYSE
16:03:44 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 386.22 USD | +0.44% |
|
-5.75% | +50.79% |
| 09-17 | CVS Health's Aetna to streamline cancer treatment approvals | RE |
| 09-11 | BofA Adjusts Price Target on Humana to $510 From $500 | MT |
| Market Cap | 46.38B 40.44B 38.19B 34.68B 64.97B 4,450B 65.24B 457B 177B 2,263B 174B 170B 7,280B | P/E 2026 * |
53.9x | P/E 2027 * | 23.8x |
|---|---|---|---|---|---|
| Enterprise Value | 53.88B 46.99B 44.37B 40.29B 75.48B 5,170B 75.8B 531B 205B 2,629B 202B 198B 8,458B | EV / Sales 2026 * |
0.33x | EV / Sales 2027 * | 0.31x |
| Free-Float |
60.3% | Yield 2026 * |
0.95% | Yield 2027 * | 0.98% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| HUM | Delayed | |
CBOE
| HUM | Real-time | |
|
Boerse Muenchen
| HUM | Real-time | |
|
Mexican S.E.
| HUM * | End-of-day quote | |
|
Xetra
| HUM | Delayed | |
|
Deutsche Boerse AG
| HUM | Delayed | |
|
Tradegate
| HUM | Real-time | |
|
Börse Stuttgart
| HUM | Delayed | |
|
Berne S.E.
| HUM | End-of-day quote | |
|
Borsa Italiana
| 1HUM | End-of-day quote |
Last Transcript: Humana Inc.
| 1 day | +0.44% | ||
| 1 week | -5.75% | ||
| Current month | +0.78% | ||
| 1 month | +1.10% | ||
| 3 months | +7.09% | ||
| 6 months | +126.63% | ||
| Current year | +50.79% |
| 1 week | 380.04 |  | 415.77 |
| 1 month | 374.29 | | 419.97 |
| Current year | 163.11 | | 428.88 |
| 1 year | 163.11 | | 428.88 |
| 3 years | 163.11 | | 530.54 |
| 5 years | 163.11 | | 571.3 |
| 10 years | 163.11 | | 571.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Rechtin
CEO | Chief Executive Officer | 55 | 2024-06-30 |
Celeste Brown
DFI | Director of Finance/CFO | 49 | 2025-01-10 |
Bobby Mukundan
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-09 |
| Director | Title | Age | Since |
|---|---|---|---|
Kurt Hilzinger
CHM | Chairman | 65 | 2013-12-31 |
Frank D'Amelio
BRD | Director/Board Member | 68 | 2003-08-31 |
Karen Katz
BRD | Director/Board Member | 69 | 2019-09-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Free | Chief Technology Officer | 2,549 | 0.0021% | ||
| 8/31/26 | Other | Chief Technology Officer | 0 | 0% | ||
| 8/1/26 | Other | Director | 544 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.44% | -5.75% | +45.82% | -18.52% | 46.17B | |
| +0.45% | -0.58% | +12.57% | -22.46% | 337B | |
| -0.80% | -1.86% | +30.14% | -7.18% | 89.84B | |
| -0.26% | -1.95% | -6.29% | -3.53% | 72.93B | |
| -2.97% | -1.97% | +102.39% | -4.05% | 33.15B | |
| -2.10% | -1.68% | +11.73% | -38.97% | 10.68B | |
| -1.76% | -7.47% | +45.28% | +305.45% | 2.41B | |
| +0.44% | -0.80% | +20.47% | -22.20% | 2.07B | |
| -4.02% | -33.78% | -49.33% | +33.60% | 1.8B | |
| Average | -1.22% | -5.87% | +23.64% | +24.68% | 66.21B | |
| Weighted average by Cap. | -0.32% | -3.12% | +20.44% | -15.31% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 163B 142B 134B 122B 228B 15,618B 229B 1,605B 619B 7,941B 611B 598B 25,550B | 169B 147B 139B 126B 236B 16,174B 237B 1,662B 642B 8,223B 633B 619B 26,458B |
| Net income | 886M 773M 729M 662M 1.24B 85.01B 1.25B 8.74B 3.37B 43.22B 3.33B 3.25B 139B | 2.02B 1.76B 1.66B 1.51B 2.83B 194B 2.84B 19.89B 7.68B 98.39B 7.58B 7.41B 317B |
| Net Debt | 7.51B 6.55B 6.18B 5.61B 10.52B 720B 10.56B 74.03B 28.57B 366B 28.2B 27.57B 1,178B | 6.41B 5.59B 5.28B 4.79B 8.98B 615B 9.02B 63.22B 24.4B 313B 24.08B 23.55B 1,006B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-18 | US$386.22 | +0.44% | 1,681,368 |
| 26-09-17 | US$384.52 | -0.05% | 850,195 |
| 26-09-16 | US$384.72 | -3.00% | 1,036,290 |
| 26-09-15 | US$396.62 | -2.56% | 852,098 |
| 26-09-14 | US$407.02 | -0.68% | 708,886 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HUM Stock
Select your edition
All financial news and data tailored to specific country editions
